Foreign Ministry has announced that beginning on Wednesday, it would no longer require travelers entering China to take a PCR test or an antigen test for COVID-19.
China starts managing COVID-19 with measures designed for combating Class B infectious diseases, instead of Class A infectious diseases.
China will manage COVID-19 with measures against Class B infectious diseases, instead of Class A infectious diseases, in a major shift of its epidemic response policies.
Powered by technologies such as virtual reality (VR), 5G and cloud computing, a training platform for interventional cardiology was launched Wednesday in a hospital in Xiamen, East China's Fujian province.
China will cut COVID-19 quarantine period for incoming travelers from 10 to 8 days, cancel the circuit breaker for inbound flights and no longer determine secondary close contacts of confirmed cases, health authorities said on Friday.
China has approved COVID-19 antigen testing as a supplementary means to improve early detection, and 10 domestically made antigen kits have been allowed for home use.
Xiamen Hospital of Traditional Chinese Medicine (TCM) was listed among the second batch of national Chinese medicine service export bases, which was released by the Ministry of Commerce recently.
The monoclonal neutralizing antibody cocktail is jointly developed by Brii Biosciences, Tsinghua University and the Third People's Hospital of Shenzhen.